drugset / Trial / NCT07482319
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
Phase 1
Not yet recruiting
15 enrolled
Beijing Geekgene Technology Co., LTD
Peking University Cancer Hospital & Institute · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
An Open-label, Single-arm, Phase I Clinical Study of GK01 Cell Injection in the Treatment of Patients with Advanced Malignant Solid Tumors
Timeline
- Start
- 2026-04
- Primary completion
- 2026-12
- Completion
- 2028-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GK01 injection | Unknown | — | — |